Hong Kong Retail REITs Stock News

Steve Leung Design Group (HKG:2262) has had a rough three months with its share price down 29%. It seems that the...

Key Insights Significant control over Keymed Biosciences by individual investors implies that the general public has...

Insiders who purchased S$5.82m worth of Republic Healthcare Limited ( HKG:8357 ) shares over the past year recouped...

As 2025 draws to a close, Asian markets are navigating a complex landscape marked by economic slowdowns in key regions like China and Japan, while investor sentiment is cautiously optimistic amid hopes for interest rate adjustments. In this environment, identifying undervalued stocks becomes crucial as investors seek opportunities that offer potential value despite broader market uncertainties.

There wouldn't be many who think Hygeia Healthcare Holdings Co., Limited's ( HKG:6078 ) price-to-earnings (or "P/E...

Modern Chinese Medicine Group Co., Ltd. ( HKG:1643 ) shareholders that were waiting for something to happen have been...

Most readers would already be aware that Luyuan Group Holding (Cayman)'s (HKG:2451) stock increased significantly by...

The Steve Leung Design Group Limited ( HKG:2262 ) share price has fared very poorly over the last month, falling by a...

Key Insights Significant insider control over Zhongyu Energy Holdings implies vested interests in company growth 65% of...

Many investors define successful investing as beating the market average over the long term. But its virtually certain...

Meituan has reported its third quarter 2025 results, with revenue rising slightly year-on-year to CNY 95,488.11 million but shifting from a CNY 12,864.70 million net profit to a CNY 18,632.45 million net loss. This move from profit to loss despite higher sales points to pressure on costs or margins, raising questions about the quality of Meituan’s current growth. Next, we’ll examine how Meituan’s swing to a sizeable quarterly net loss could reshape its previously margin-focused investment...

Hansoh Pharmaceutical Group (SEHK:3692) just secured fresh National Reimbursement Drug List approvals for new Ameile indications, plus renewals for Saint Luolai and Hengmu, a policy shift that could reshape its revenue mix from 2026. See our latest analysis for Hansoh Pharmaceutical Group. That backdrop helps explain why sentiment has swung so hard in Hansoh’s favour, with a 30 day share price return of 18.79 percent and a one year total shareholder return of 137.26 percent signalling strong,...

Greentown Service Group (SEHK:2869) just reshaped its board, adding new audit, remuneration, and nomination committees, while a non executive director steps down as part of a broader succession plan. See our latest analysis for Greentown Service Group. These governance moves come after a solid run, with the latest HK$4.45 share price supported by a double digit year to date share price return, but set against a weak five year total shareholder return. This suggests momentum is rebuilding from...

Dekon Food and Agriculture Group (SEHK:2419) just released its November 2025 operating data, showing steady pig and poultry volumes alongside modest price gains, including a roughly 2% lift in yellow feathered broiler prices month on month. See our latest analysis for Dekon Food and Agriculture Group. The upbeat November pricing data lands after a strong run, with year to date share price return of 136.18% and a 1 year total shareholder return of 126.21%, even though recent 90 day share price...

Texwinca Holdings (SEHK:321) has posted its H1 2026 numbers with revenue of HK$2.7 billion and net income of HK$112 million, translating to EPS of HK$0.08 as the market weighs what that means for the rest of the year. The company has seen revenue move from HK$3.0 billion in H1 2025 to HK$2.7 billion in H1 2026, while net income shifted from HK$102 million to HK$112 million over the same periods, creating a mixed backdrop for how investors read the latest margin profile. All told, the release...

BYD (SEHK:1211) has quietly slipped about 4% over the past month and roughly 7% in the past 3 months, which is exactly when long term investors start asking whether recent weakness is an opportunity. See our latest analysis for BYD. Despite the recent softness in its share price, BYD’s 13.11% year to date share price return and solid multi year total shareholder returns suggest momentum is pausing rather than breaking, as investors reassess growth and competitive risks around electric...

With its stock down 26% over the past three months, it is easy to disregard Bloks Group (HKG:325). However, stock...

Haidilao International Holding Ltd. was removed from the Hang Seng China Enterprises Index on 5 December 2025, altering its status within one of Hong Kong’s key benchmark indices. This index removal matters because it can prompt forced buying and selling by index-tracking funds, potentially reshaping Haidilao’s shareholder base and trading profile. Next, we will examine how Haidilao’s exit from the Hang Seng China Enterprises Index influences its investment narrative and perceived market...

For many, the main point of investing in the stock market is to achieve spectacular returns. And highest quality...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

As global markets keep a close watch on the Federal Reserve's final meeting of the year, Asian markets are also navigating their own set of economic signals, such as manufacturing slowdowns and service sector expansions. In this context, penny stocks—often smaller or newer companies—continue to hold relevance as potential growth opportunities. Despite being an outdated term for some, these stocks can offer significant upside when backed by strong financial health and fundamentals.

If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...